Benefits of arterial enhancement fraction in the evaluation of the effect of transarterial chemoembolization

Abstract

The aim of our work was to determine the values of arterial enhancement fraction (AEF) for two most common liver tumors - hepatocellular carcinoma (HCC) and colorectal liver metastases (CLM), as well as for the residues after transarterial chemoembolization (TACE) of these tumors.

Keywords

• liver tumor
• transarterial chemoembolisation
• arterial saturation